16563134

Source:http://linkedlifedata.com/resource/pubmed/id/16563134

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038215, umls-concept:C0205210, umls-concept:C0439234, umls-concept:C0454270
pubmed:issue	2
pubmed:dateCreated	2006-3-27
pubmed:abstractText	We evaluated the efficacy and complications of high dose rate (HDR) brachytherapy using iridium-192 (192Ir) combined with external beam radiotherapy (EBRT) in patients with prostate cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9440237
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Iridium Radioisotopes
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0919-8172
pubmed:author	pubmed-author:KomatsuKazutoK, pubmed-author:KoshidaKiyoshiK, pubmed-author:MizokamiAtsushiA, pubmed-author:NamikiMikioM, pubmed-author:ShigeharaKazuyoshiK
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	116-21
pubmed:dateRevised	2006-10-30
pubmed:meshHeading	pubmed-meshheading:16563134-Aged, pubmed-meshheading:16563134-Aged, 80 and over, pubmed-meshheading:16563134-Brachytherapy, pubmed-meshheading:16563134-Disease-Free Survival, pubmed-meshheading:16563134-Humans, pubmed-meshheading:16563134-Iridium Radioisotopes, pubmed-meshheading:16563134-Male, pubmed-meshheading:16563134-Middle Aged, pubmed-meshheading:16563134-Prognosis, pubmed-meshheading:16563134-Prostatic Neoplasms, pubmed-meshheading:16563134-Radiotherapy Dosage, pubmed-meshheading:16563134-Survival Rate, pubmed-meshheading:16563134-Time Factors
pubmed:year	2006
pubmed:articleTitle	Four year clinical statistics of iridium-192 high dose rate brachytherapy.
pubmed:affiliation	Department of Urology, Kanazawa University Hospital, Kanazawa City, Japan.
pubmed:publicationType	Journal Article, Clinical Trial